Amgen Inc (AMGN)

217.15 -6.31  -2.82% NASDAQ Oct 28, 11:19 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/13/2020 Dividends Amount: 1.60, Declared Date: Oct 21 2020, Pay Date: Dec 08 2020
10/29/2020 14:00 PDT Misc Amgen Inc Third Quarter Earnings Conference Call for 2020
10/29/2020 Earnings Amgen Inc Third Quarter Earnings for 2020 Release
08/14/2020 Dividends Amount: 1.60, Declared Date: Jul 23 2020, Pay Date: Sep 08 2020
07/28/2020 14:00 PDT Misc Amgen Inc Second Quarter Earnings Conference Call for 2020
07/28/2020 Earnings Amgen Inc Second Quarter Earnings Result for 2020
05/19/2020 11:00 PDT Misc Amgen Inc Annual General Meeting for 2019
05/15/2020 Dividends Amount: 1.60, Declared Date: Mar 04 2020, Pay Date: Jun 08 2020
04/30/2020 Earnings Amgen Inc First Quarter Earnings Result for 2020
04/30/2020 14:00 PDT Misc Amgen Inc First Quarter Earnings Conference Call for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.amgen.com
  • Investor Relations URL: http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Oct. 29, 2020
  • Last Earnings Release: Jul. 28, 2020
  • Next Ex-Dividend Date: Nov. 13, 2020
  • Last Ex-Dividend Date: Aug. 14, 2020
  • Description: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).

Top Fund Holders

Symbol Name Weighting
IBB iShares Nasdaq Biotechnology ETF 7.27%
DIA SPDR® Dow Jones Industrial Avrg ETF Tr 5.34%
VPMCX Vanguard PRIMECAP Inv 4.00%
XLV Health Care Select Sector SPDR® ETF 3.29%
RMEBX American Funds American Mutual R2E 2.64%
RCEEX American Funds Capital Income Bldr R2E 1.99%
RICAX American Funds Invmt Co of Amer R1 1.66%
VYM Vanguard High Dividend Yield ETF 1.52%
RWIEX American Funds Capital World Gr&Inc R4 1.33%
VTV Vanguard Value ETF 1.18%
QQQ Invesco QQQ Trust 1.12%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.